"Life changing tech" #Respiro #DTx youtube.com/watch?v=gWp66J…

Amiko among the 10 European IoT startups to watch in 2018 and beyond Amiko @breedreply #iot eu-startups.com/2018/09/10-eur… via EU-Startups

The AI technology helping asthma sufferers breathe easier > bit.ly/2MKEUCe Arm's Editor-in-Chief, Brian Fuller, investigates Amiko's Respiro smart inhaler (via Hackster.io). #ArmTechCon #MachineLearning

Herzlichen Glückwunsch an das #Startup Amiko aus #Bensheim, das für den 3. #Healthi-Award nominiert ist: amiko.io Das junge Unternehmen hat intelligente Sensoren für Inhalationsgeräte entwickelt. Am 7.11. steht der Award-Gewinner in der Kategorie #Startup fest.

Digital Therapies - a great opportunity for Italy to become a leader in clinical research, from Giuseppe Recchia's presentation at Regione Lombardia, with AFI, AIFA, ISS. #Respiro #DTx

Su AboutPharma ottobre 2018 la mia intervista su accordo 23andMe e GSK per identicare nuovi bersagli biologici geneticamente validati ed accelerare la scoperta di nuovi farmaci...futuro #DrugDiscovery massimo ascani

Amiko in Düsseldorf for MEDICA ! You can find us with the @EIT_Digital at our booth, Hall 15 - E60.

Heutiger Schlussakt beim #MedicaEconForum: Nominierte #Startups der #Healthi-Initiative 2018 stellen ihre Ideen für die Gesundheit von morgen vor. health-i.de/de/rueckblick/…

Here are 5 different ways in which #AI is redefining #respiratory #care, Amiko Adherium Limited , Propeller Health Asthma UK Asthma COPD Overlap NuvoAir Medical @coherohealth FLUIDDA Philips COPD Foundation forbes.com/sites/shourjya…

We are featured in Forbes! 4 Ways In Which AI Is Revolutionizing Respiratory Care #Respiro #DTx #digitalmedicine forbes.com/sites/shourjya…

From Italy #Respiro, a #AI-powered Digital Therapy #DTx for Patients with chronic respiratory diseases. “Artificial Intelligence and Clinical Trials” Duilio Macchi al PoliHub Milan 30.112018 #AI4RCT

Rising stars - a look at the Top #IoT Start-Ups, by sector🏅bit.ly/2UYAi04 Future Mind MachineMetrics

We're proud that preliminary data from the study we're running with Reply and U Twente, in partnership with Unifarm, and with EIT Digital's support, shows improved adherence (+52%), inhalation technique (+48%), and Asthma Control Test scores (+40,94%).

For our Dutch Readers: Waar blijft de slimme inhalator voor longpatiënten? Artikel Frederieke Jacobs SmartHealth. #ACT4Y #ehealth okt.to/gcVL3M

For our Dutch readers: Snelle uitrol van digitale astma service ACT4Y gepland, zegt CCO Amiko en activity lead #ACT4Y bij EIT Digital in interview met Martijn Kregting in ICT&health | NL okt.to/yCrkN0

For our Dutch readers: Astmapatiënt blijft therapietrouw dankzij sensoren, Artikel in Dan McVeagh over EIT Digital’s Wellbeing Innovation Activity #ACT4Y, dat is ontwikkeld samen met University of Twente (inactive), Amiko en Santer Reply. okt.to/K65ChA

DTx e Companies : what role for the country? Massimo Beccaria introduce Amiko AMICOMED daVinci Digital Therapeutics, Sandoz Otsuka , AstraZeneca e Assolombarda

Today, we are excited to announce our collaboration with Berry Global to launch the RS01X, a digitally-connected single-dose dry powder inhaler powered by Respiro: amiko.io/2020/12/07/ami…

We are featured in OINDP News! Amiko and Berry Global announce partnership oindpnews.com/2020/12/berry-…

Amiko is featured in the latest issue of @ondrugdelivery focused on connected drug delivery. Have a look - we discuss the RS01X, a digitally-connected single-dose dry powder inhaler powered by Respiro! ondrugdelivery.com/magazines/conn…